Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Lilian Walther-Jallow"'
Autor:
Ashis Kumar, Sowmya Ramesh, Lilian Walther-Jallow, Annika Goos, Vignesh Kumar, Åsa Ekblad, Vrisha Madhuri, Cecilia Götherström
Publikováno v:
Regenerative Therapy, Vol 26, Iss , Pp 324-333 (2024)
Introduction: Cell therapy has been increasingly considered to treat diseases, but it has been proven difficult to manufacture the same product at multiple manufacturing sites. Thus, for a wider implementation an alternative is to have one manufactur
Externí odkaz:
https://doaj.org/article/bfe0c0c6d9564680869fca5ec55230a6
Autor:
Emine Begüm Gençer, Yuk Kit Lor, Fawaz Abomaray, Samir El Andaloussi, Maria Pernemalm, Nidhi Sharma, Daniel W Hagey, André Görgens, Manuela O Gustafsson, Katarina Le Blanc, Mawaddah Asad Toonsi, Lilian Walther-Jallow, Cecilia Götherström
Publikováno v:
Stem Cell Research & Therapy, Vol 15, Iss 1, Pp 1-18 (2024)
Abstract Background Mesenchymal stem/stromal cells (MSCs) can regenerate tissues through engraftment and differentiation but also via paracrine signalling via extracellular vesicles (EVs). Fetal-derived MSCs (fMSCs) have been shown, both in vitro and
Externí odkaz:
https://doaj.org/article/54fa88addc4b496387c5dedc29fe0c11
Autor:
Anna L David, Mats Johansson, Magnus Westgren, Belinda Crowe, Dick Oepkes, Melissa Hill, Lyn S Chitty, Catherine DeVile, Peter Lindgren, Eva Åström, Cecilia Götherström, Nils-Eric Sahlin, Rachel L Sagar, Annabelle Forsmark, Vera Franzen, Göran Hermeren, Caroline Lindemans, Wouter Nijhuis, Mirko Rehberg, Ralph Sakkers, O Semler, Mikael Sundin, Lilian Walther-Jallow, E J T Joanne Verweij
Publikováno v:
BMJ Open, Vol 14, Iss 6 (2024)
Introduction Severe osteogenesis imperfecta (OI) is a debilitating disease with no cure or sufficiently effective treatment. Mesenchymal stem cells (MSCs) have good safety profile, show promising effects and can form bone. The Boost Brittle Bones Bef
Externí odkaz:
https://doaj.org/article/582a3f441343419db9a89157809ffc1c
Publikováno v:
Stem Cells Translational Medicine, Vol 9, Iss 2, Pp 148-157 (2020)
Abstract Imagine the profits in quality of life that can be made by treating inherited diseases early in life, maybe even before birth! Immense cost savings can also be made by treating diseases promptly. Hence, prenatal stem cell therapy holds great
Externí odkaz:
https://doaj.org/article/e72fc10c781c4da6bcb5e38e5d2dcfcb
Autor:
Venkatramanan Mohanram, Ulrika Johansson, Annette E Sköld, Joshua Fink, Sushil Kumar Pathak, Barbro Mäkitalo, Lilian Walther-Jallow, Anna-Lena Spetz
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e21171 (2011)
Dendritic cells (DCs) are activated by signaling via pathogen-specific receptors or exposure to inflammatory mediators. Here we show that co-culturing DCs with apoptotic HIV-infected activated CD4(+) T cells (ApoInf) or apoptotic uninfected activated
Externí odkaz:
https://doaj.org/article/60cc95b5064a4736b542da6028bc1ee3
Autor:
Gülşen Ozkaya Sahin, Emma J Bowles, Joe Parker, Hannes Uchtenhagen, Enas Sheik-Khalil, Stephen Taylor, Oliver G Pybus, Barbro Mäkitalo, Lilian Walther-Jallow, Mats Spångberg, Rigmor Thorstensson, Adnane Achour, Eva Maria Fenyö, Guillaume B E Stewart-Jones, Anna-Lena Spetz
Publikováno v:
PLoS Pathogens, Vol 6, Iss 9, p e1001084 (2010)
Neutralizing antibodies (NAb) able to react to heterologous viruses are generated during natural HIV-1 infection in some individuals. Further knowledge is required in order to understand the factors contributing to induction of cross-reactive NAb res
Externí odkaz:
https://doaj.org/article/3f84311627eb4101b2883fa512727496
Publikováno v:
Clinical Obstetrics & Gynecology. 64:898-903
The aim of this study was to provide a brief overview on the background and rationale on treating fetuses and children suffering from osteogenesis imperfecta (OI) with mesenchymal stem cells (MSCs). MSCs ability to migrate, engraft, and differentiate
Publikováno v:
Current Osteoporosis Reports
Purpose of Review Osteogenesis imperfecta (OI) is a chronic disease with few treatment options available. The purpose of this review is to provide an overview on treating OI with mesenchymal stem cells (MSC). Recent Findings Off-the-shelf MSC have a
Publikováno v:
Stem Cells Translational Medicine
Stem Cells Translational Medicine, Vol 9, Iss 2, Pp 148-157 (2020)
Stem Cells Translational Medicine, Vol 9, Iss 2, Pp 148-157 (2020)
Imagine the profits in quality of life that can be made by treating inherited diseases early in life, maybe even before birth! Immense cost savings can also be made by treating diseases promptly. Hence, prenatal stem cell therapy holds great promise
Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma
Autor:
Hareth Nahi, Michael Chrobok, Stephan Meinke, Charlotte Gran, Nicole Marquardt, Gabriel Afram, Tolga Sutlu, Mari Gilljam, Birgitta Stellan, Arnika K. Wagner, Pontus Blomberg, Per-Henrik Holmqvist, Lilian Walther-Jallow, Karin Mellström, Johan Liwing, Charlotte Gustafsson, Robert Månsson, Monika Klimkowska, Gösta Gahrton, Johan Lund, Per Ljungman, Hans-Gustaf Ljunggren, Evren Alici
Publikováno v:
Cell reports. Medicine. 3(2)
Few approaches have been made toward exploring autologous NK cells in settings of cancer immunotherapy. Here, we demonstrate the feasibility of infusing multiple doses of